Healthcare Distribution Alliance – Patients Move Us.
Share Print
blog banner

HDA Blog

Traceability Blog Entries

DSCSA 2023: Dispensers’ Role and Responsibilities

Posted

Healthcare Distribution Alliance (HDA) is hosting a webinar series to discuss the upcoming Drug Supply Chain Security Act (DSCSA) requirements. These webinars, which focus on education specific to dispensers, will lead up to HDA’s annual Traceability Seminar on October 12-14 in Washington D.C.

Read more...

DSCSA 2023: The Role of Service Providers and the VRS

Posted

HDA is hosting a webinar series to discuss the upcoming Drug Supply Chain Security Act (DSCSA) requirements. These webinars, which focus on education specific to dispensers, will lead up to HDA’s annual Traceability Seminar on October 12–14 in Washington D.C.

Read more...

Prepare for 2023 DSCSA Compliance with HDA's Latest Industry Resources

Posted by Jaidalyn Rand

In less than 18 months, the Drug Supply Chain Security Act (DSCSA) will reach its final milestone, culminating a 10-year implementation process across the healthcare supply chain. To help manufacturers and distributors prepare for interoperable data exchange, HDA, along with technical expertise from distributor- and manufacturer-member task force participants, has published new guidelines and other resources with the latest information and best practices.

Read more...

New HDA Video Highlights Industry Progress Toward DSCSA Implementation

Posted

With the deadline to implement the 2013 Drug Supply Chain Security Act (DSCSA) now less than two years away, HDA has released a new video that highlights the great progress that has been made by industry to implement DSCSA and some of the biggest challenges that still remain.

Read more...

HDA’s Davis Shares 2022 Strategic Priorities Under Increased Awareness of Supply Chains

Posted

Events spanning COVID-19 vaccine distribution to shipping containers held up at port have made the supply chain a “kitchen-table” issue during the past year. Many industries experienced notable disruptions in their delivery of goods and supplies; however, as noted by President and CEO Chip Davis, “[P]harmacies, health systems and physicians’ offices, more than 180,000 across the country, remain stocked with the lifesaving medications and vaccines patients need. That didn’t happen by accident.” Davis’ perspective was featured alongside healthcare supply chain association leaders as part of Chain Drug Review’s annual “Pharmacy Outlook” feature.

Read more...
View more
© 2020 Healthcare Distribution Alliance. All rights reserved.
HDA: E | C | C2 | NF | O365